XML 33 R22.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share Based Payments (Tables)
6 Months Ended
Aug. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Assumptions used to Calculate Fair Value of Options on Date of Grant
The following assumptions were used to calculate the fair value of the Company’s options on the date of grant during the six months ended August 31, 2015 and 2016:
 
 
Six Months Ended August 31,
 
2015
 
2016
Risk-Free Interest Rate:
1.3% - 1.4%
 
0.9% - 1.2%
Expected Dividend Yield:
0%
 
0%
Expected Life (Years):
4.3
 
4.3
Expected Volatility:
57.2% - 64.6%
 
58.6% - 60.0%
Summary of Stock Options Outstanding and Activity
The following table presents a summary of the Company’s stock options outstanding at August 31, 2016, and stock option activity during the six months ended August 31, 2016 (“Price” reflects the weighted average exercise price per share; "Aggregate Intrinsic Value" dollars in thousands):
 
 
Options
 
Price
 
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
Outstanding, beginning of period
1,948,384

 
$
6.36

 
 
 
 
Granted
174,678

 
2.38

 
 
 
 
Exercised
12,515

 
1.62

 
 
 
 
Forfeited
4,375

 
8.28

 
 
 
 
Expired
18,432

 
44.68

 
 
 
 
Outstanding, end of period
2,087,740

 
5.71

 
6.6
 
$
1,540

Exercisable, end of period
1,211,940

 
5.71

 
5.1
 
$
785


Summary of Nonvested Options and Changes
A summary of the Company’s nonvested options at August 31, 2016, and changes during the six months ended August 31, 2016, is presented below:
 
 
Options
 
Weighted Average
Grant Date
Fair Value
Nonvested, beginning of period
830,803

 
$
3.71

Granted
174,678

 
1.13

Vested
125,306

 
5.03

Forfeited
4,375

 
4.22

Nonvested, end of period
875,800

 
3.00

Summary of Restricted Stock Grants Outstanding and Activity
The following table presents a summary of the Company’s restricted stock grants outstanding at August 31, 2016, and restricted stock activity during the six months ended August 31, 2016 (“Price” reflects the weighted average share price at the date of grant):
 
 
Awards
 
Price
Grants outstanding, beginning of period
212,995

 
$
7.12

Granted
226,452

 
2.76

Vested (restriction lapsed)
228,871

 
4.22

Grants outstanding, end of period
210,576

 
5.59

Stock-Based Compensation Expense and Related Tax Benefits Recognized
The following table summarizes stock-based compensation expense recognized by the Company during the three and six months ended August 31, 2015 and 2016. The company did not recognize any tax benefits related to stock-based compensation during the periods presented below. 
 
Three Months Ended August 31,
 
Six Months Ended August 31,
 
2015
 
2016
 
2015
 
2016
Station operating expenses
$
521

 
$
197

 
$
1,245

 
$
534

Corporate expenses
1,140

 
463

 
2,520

 
982

Stock-based compensation expense included in operating expenses
$
1,661

 
$
660

 
$
3,765

 
$
1,516